Companies: 10,795·Total market cap: $144.5T
Kadmon Holdings, Inc.

Kadmon Holdings, Inc.

KDMNNYSEHealthcare
$9.50
+$0.00(+0.00%)
Market Cap$0
P/E Ratio
52W High$9.495
52W Low$9.48
Overview

Kadmon Holdings, Inc. (KDMN) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · KDMN · as of Mar 4, 2021

Latest filing snapshot

127
+12+10.43%vs prior year

Kadmon Holdings, Inc. (KDMN) employee data is sourced from the annual SEC 10-K filing. As of 2020, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2020-12-31·Full-time · Global
Total Employees
127
Change (1Y)
+12
Growth % (1Y)
+10.43%
Revenue / Employee
$65.3K
Net Income / Employee
$-857.6K
Market Cap
$0M

KDMN Employee Count

2016 – 2020 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2021-03-04127+12+10.43%
2020-03-05115-1-0.86%
2019-03-07116+15+14.85%
2018-03-06101-17-14.41%
2017-03-22118

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Calliditas Therapeutics AB (publ)
CALT
Calliditas Therapeutics AB (publ)
222
#2
Kadmon Holdings, Inc.
KDMN
Kadmon Holdings, Inc.YOU
127
#3
CTI BioPharma Corp.
CTIC
CTI BioPharma Corp.
127
#4
Ambrx Biopharma Inc.
AMAM
Ambrx Biopharma Inc.
87
#5
BELLUS Health Inc.
BLU
BELLUS Health Inc.
74
#6
DICE Therapeutics, Inc.
DICE
DICE Therapeutics, Inc.
71
#7
CinCor Pharma, Inc.
CINC
CinCor Pharma, Inc.
19
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · KDMN peer comparison

About KDMN employees

KDMN Employees · Headcount

Kadmon Holdings, Inc. (KDMN) employee data is sourced from the annual SEC 10-K filing. As of 2020, Kadmon Holdings, Inc. had 127 full-time employees globally. Full-time employees only. Global consolidated headcount.

Kadmon Holdings, Inc. employs 127 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $65,260, reflecting the company's operational efficiency.

Kadmon Holdings, Inc.'s workforce increased by 12 (10.43%) in 2020 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Kadmon Holdings, Inc.'s revenue per employee of $65,260 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

KDMN Employees · 5 questions

As of the latest SEC 10-K filing (2020), Kadmon Holdings, Inc. had 127 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Kadmon Holdings, Inc. employee counthow many employees does Kadmon Holdings, Inc. haveKDMN total employees 2020

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2021-03-04